| Literature DB >> 26975877 |
Li-Ting Kao1,2, Herng-Ching Lin2, Shiu-Dong Chung2,3, Chao-Yuan Huang4,5.
Abstract
Even though epididymoorchitis and testicular cancer (TC) may have similar pathophysiological pathways, no prior study has attempted to determine the association between these two diseases. This case-control study investigated the relationship between TC and prior epididymoorchitis by using a large population-based database. We used the Taiwan Longitudinal Health Insurance Database 2005 to select 372 patients who had received a diagnosis of TC and 3,720 age-matched controls without TC. We found that of the total sample of 4,092 patients, 53 (1.3%) had received a diagnosis of epididymoorchitis prior to the index date. Patients with TC had a higher prevalence of prior epididymoorchitis than that of patients without TC (11.0% vs. 0.3%, p < 0.001). Conditional logistic regression showed that prior epididymoorchitis was significantly associated with TC (crude OR = 38.24, 95% CI = 19.91-73.46). The association remained statistically significant even after adjustment for the other variables (OR = 47.17, 95% CI = 23.83-93.40). This study showed that patients with TC have higher odds of prior epididymoorchitis than do those without TC even after adjustment for potential confounders.Entities:
Mesh:
Year: 2016 PMID: 26975877 PMCID: PMC4791681 DOI: 10.1038/srep23079
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Sociodemographic characteristics and medical comorbidities of testicular cancer patients and controls (n = 4,092).
| Patients with Testicular Cancer | Controls | ||||
|---|---|---|---|---|---|
| Variables | No. | (%) | No. | (%) | |
| Age, mean (standard deviation) | 34.4 (18.9) | 34.2 (18.9) | 0.865 | ||
| Monthly insured income | 0.970 | ||||
| ≤NT$15,840 | 194 | (52.2) | 1,932 | (51.9) | |
| NT$15,841-25,000 | 82 | (22.0) | 840 | (22.6) | |
| ≥NT$25,001 | 96 | (25.8) | 948 | (25.5) | |
| Urbanization level | <0.001 | ||||
| 1 | 90 | (24.2) | 1,158 | (31.1) | |
| 2 | 118 | (31.7) | 1,058 | (28.4) | |
| 3 | 39 | (10.5) | 638 | (17.2) | |
| 4 | 45 | (12.1) | 468 | (12.6) | |
| 5 | 80 | (21.5) | 398 | (10.7) | |
| Geographic region | <0.001 | ||||
| Northern | 14,321 | (37.9) | 1,844 | (49.6) | |
| Central | 182 | (48.9) | 906 | (24.4) | |
| Southern | 45 | (12.1) | (920 | (24.7) | |
| Eastern | 4 | (1.1) | 50 | (1.3) | |
| Inguinal hernia | 13 | (3.5) | 106 | (2.9) | 0.480 |
| Cryptorchidism | 2 | (0.5) | 10 | (0.3) | 0.361 |
| Testicular microlithiasis | 15 | (4.0) | 22 | (0.6) | <0.001 |
| Mumps orchitis | 0 | (0) | 2 | (0.1) | -- |
Relationship between testicular cancer and prior epididymoorchitis (n = 4092).
| Presence of Prior Epididymoorchitis | Patients with Testicular Cancer | Controls | |||
|---|---|---|---|---|---|
| No. | % | No. | % | ||
| Yes | 41 | (11.0) | 12 | (0.3) | <0.001 |
| No | 331 | (89.0) | 3,708 | (99.7) | |
Crude and adjusted odds ratio for testicular cancer (n = 4092).
| Variables | Testicular Cancer Occurrences | |||
|---|---|---|---|---|
| Crude OR (95% CI) | Adjusted OR (95% CI) | |||
| Prior epididymoorchitis | 38.24 (19.91–73.46) | <0.001 | 47.17 (23.83–93.40) | <0.001 |
| Urbanization level | ||||
| 1 | 1.00 | 1.00 | ||
| 2 | 1.44 (1.08–1.91) | 0.014 | 1.29 (0.94–1.77) | 0.110 |
| 3 | 0.79 (0.53–1.16) | 0.225 | 0.56 (0.37–0.87) | 0.009 |
| 4 | 1.24 (0.85–1.80) | 0.264 | 0.72 (0.47–1.12) | 0.145 |
| 5 | 2.59 (1.87–3.57) | <0.001 | 1.80 (1.24–2.61) | 0.002 |
| Geographic region | ||||
| Northern | 1.00 | 1.00 | ||
| Central | 2.63 (2.08–3.32) | <0.001 | 2.98 (2.26–3.95) | <0.001 |
| Southern | 0.64 (0.45–0.90) | 0.0111 | 0.59 (0.40–0.86) | 0.006 |
| Eastern | 1.05 (0.37–2.94) | 0.9316 | 0.86 (0.27–2.79) | 0.801 |
| Testicular microlithiasis | 7.06 (3.63–13.74) | <0.001 | 5.88 (2.77–12.48) | <0.001 |
Note: The adjusted odds ratios were derived from a conditional logistic regression model and adjusted for potential confounders.